Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large multifunctional peptidase 7 (LMP7/PSMB8/Beta5i) is an inducible catalytic component of the immunoproteasome critical for immune surveillance via antigen processing. Its selective inhibition represents a promising strategy against certain cancers such as multiple myeloma while also playing roles in autoimmunity due to its central function in shaping peptide repertoires presented on MHC class I molecules.
Selective inhibition of LMP7 activity, suppression of ubiquitinated protein turnover, induction of apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large multifunctional peptidase 7 (LMP7).